Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Immunity & Ageing
Published in: Immunity & Ageing 1/2011

Open Access 01-12-2011 | Research

Aging impacts isolated lymphoid follicle development and function

Authors: Keely G McDonald, Matthew R Leach, Conway Huang, Caihong Wang, Rodney D Newberry

Published in: Immunity & Ageing | Issue 1/2011

Login to get access

Abstract

Background

Immunosenescence is the age-related decline and dysfunction of protective immunity leading to a marked increase in the risk of infections, autoimmune disease, and cancer. The majority of studies have focused on immunosenescence in the systemic immune system; information concerning the effect of aging on intestinal immunity is limited. Isolated lymphoid follicles (ILFs) are newly appreciated dynamic intestinal lymphoid structures that arise from nascent lymphoid tissues, or cryptopatches (CP), in response to local inflammatory stimuli. ILFs promote "homeostatic" responses including the production of antigen-specific IgA, thus playing a key role in mucosal immune protection. ILF dysfunction with aging could contribute to immunosenescence of the mucosal system, and accordingly we examined phenotypic and functional aspects of ILFs from young (2 month old) and aged (2 year old) mice.

Results

We observed that aged mice have increased numbers of ILFs and increased numbers of structures corresponding to an early stage of CPs transforming into ILFs. The cellular composition of ILFs in aged mice is altered with a smaller B-lymphocyte population and an increased T-lymphocyte population. The ILF T-lymphocyte population is notable by the presence of CD4+ CD8αα+ T-lymphocytes, which are absent from the systemic compartment. The smaller B-lymphocyte population in ILFs from aged mice is directly correlated with decreased mRNA and protein expression of CCL20 and CXCL13, two chemokines that play crucial roles in recruiting B-lymphocytes into ILFs. Aged mice had elevated levels of serum and fecal immunoglobulins and despite the decreased B-lymphocyte population, ILFs from aged mice displayed increased IgA production. The immunoglobulin repertoire was skewed in aged mice, and ILFs demonstrated a repertoire usage similar to that of the systemic pool in both young and aged mice.

Conclusions

Here we observed that ILF development, cellular composition, and immunoglobulin production are altered with aging suggesting that ILF dysfunction contributes to mucosal immunosenescence.
Appendix
Available only for authorised users
Literature
1.
Castle SC, Uyemura K, Rafi A, Akande O, Makinodan T: Comorbidity is a better predictor of impaired immunity than chronological age in older adults. J Am Geriatr Soc. 2005, 53 (9): 1565-1569. 10.1111/j.1532-5415.2005.53512.x.PubMed
2.
Castle SC, Uyemura K, Fulop T, Makinodan T: Host resistance and immune responses in advanced age. Clin Geriatr Med. 2007, 23 (3): 463-479. 10.1016/j.cger.2007.03.005.PubMed
3.
Castle SC: Impact of age-related immune dysfunction on risk of infections. Z Gerontol Geriatr. 2000, 33 (5): 341-349. 10.1007/s003910070030.PubMed
4.
Pawelec G: Immunosenescence: impact in the young as well as the old?. Mech Ageing Dev. 1999, 108 (1): 1-7. 10.1016/S0047-6374(99)00010-X.PubMed
5.
Hakim FT, Gress RE: Immunosenescence: deficits in adaptive immunity in the elderly. Tissue Antigens. 2007, 70 (3): 179-189. 10.1111/j.1399-0039.2007.00891.x.PubMed
6.
Janssens JP, Krause KH: Pneumonia in the very old. Lancet Infect Dis. 2004, 4 (2): 112-124. 10.1016/S1473-3099(04)00931-4.PubMed
7.
Castle SC: Clinical relevance of age-related immune dysfunction. Clin Infect Dis. 2000, 31 (2): 578-585. 10.1086/313947.PubMed
8.
Bouree P: Immunity and immunization in elderly. Pathol Biol (Paris). 2003, 51 (10): 581-585.
9.
Kang I, Hong MS, Nolasco H, Park SH, Dan JM, Choi JY, Craft J: Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine. J Immunol. 2004, 173 (1): 673-681.PubMed
10.
Zhang HG, Grizzle WE: Aging, immunity, and tumor susceptibility. Immunol Allergy Clin North Am. 2003, 23 (1): 83-102. 10.1016/S0889-8561(02)00085-1.PubMed
11.
Johnson SA, Cambier JC: Ageing, autoimmunity and arthritis: senescence of the B cell compartment - implications for humoral immunity. Arthritis Res Ther. 2004, 6 (4): 131-139. 10.1186/ar1180.PubMedCentralPubMed
12.
Schmucker DL, Heyworth MF, Owen RL, Daniels CK: Impact of aging on gastrointestinal mucosal immunity. Dig Dis Sci. 1996, 41 (6): 1183-1193. 10.1007/BF02088236.PubMed
13.
Schmucker DL, Owen RL, Outenreath R, Thoreux K: Basis for the age-related decline in intestinal mucosal immunity. Clin Dev Immunol. 2003, 10 (2-4): 167-172. 10.1080/10446670310001642168.PubMedCentralPubMed
14.
Fujihashi K, McGhee JR: Mucosal immunity and tolerance in the elderly. Mech Ageing Dev. 2004, 125 (12): 889-898. 10.1016/j.mad.2004.05.009.PubMed
15.
Lindner AE: Inflammatory bowel disease in the elderly. Clin Geriatr Med. 1999, 15 (3): 487-497.PubMed
16.
Grimm IS, Friedman LS: Inflammatory bowel disease in the elderly. Gastroenterol Clin North Am. 1990, 19 (2): 361-389.PubMed
17.
McDonald KG, McDonough JS, Newberry RD: Adaptive immune responses are dispensable for isolated lymphoid follicle formation: antigen-naive, lymphotoxin-sufficient B lymphocytes drive the formation of mature isolated lymphoid follicles. J Immunol. 2005, 174 (9): 5720-5728.PubMed
18.
McDonald KG, McDonough JS, Wang C, Kucharzik T, Williams IR, Newberry RD: CC chemokine receptor 6 expression by B lymphocytes is essential for the development of isolated lymphoid follicles. Am J Pathol. 2007, 170 (4): 1229-1240. 10.2353/ajpath.2007.060817.PubMedCentralPubMed
19.
Hamada H, Hiroi T, Nishiyama Y, Takahashi H, Masunaga Y, Hachimura S, Kaminogawa S, Takahashi-Iwanaga H, Iwanaga T, Kiyono H: Identification of multiple isolated lymphoid follicles on the antimesenteric wall of the mouse small intestine. J Immunol. 2002, 168 (1): 57-64.PubMed
20.
Lorenz RG, Chaplin DD, McDonald KG, McDonough JS, Newberry RD: Isolated Lymphoid Follicle Formation Is Inducible and Dependent Upon Lymphotoxin-Sufficient B Lymphocytes, Lymphotoxin beta Receptor, and TNF Receptor I Function. J Immunol. 2003, 170 (11): 5475-5482.PubMed
21.
Lorenz RG, Newberry RD: Isolated Lymphoid Follicles Can Function as Sites for Induction of Mucosal Immune Responses. Ann N Y Acad Sci. 2004, 1029: 44-57. 10.1196/annals.1309.006.PubMed
22.
Wang C, McDonald KG, McDonough JS, Newberry RD: Murine isolated lymphoid follicles contain follicular B-lymphocytes with a mucosal phenotype. Am J Physiol Gastrointest Liver Physiol. 2006, 291 (4): G595-604. 10.1152/ajpgi.00525.2005. Epub 2006 Jun 15PubMedCentralPubMed
23.
McDonald KG, McDonough JS, Dieckgraefe BK, Newberry RD: Dendritic cells produce CXCL13 and participate in the development of murine small intestine lymphoid tissues. Am J Pathol. 176 (5): 2367-2377. 10.2353/ajpath.2010.090723.
24.
Ansel KM, Ngo VN, Hyman PL, Luther SA, Forster R, Sedgwick JD, Browning JL, Lipp M, Cyster JG: A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature. 2000, 406 (6793): 309-314. 10.1038/35018581.PubMed
25.
Velaga S, Herbrand H, Friedrichsen M, Jiong T, Dorsch M, Hoffmann MW, Forster R, Pabst O: Chemokine receptor CXCR5 supports solitary intestinal lymphoid tissue formation, B cell homing, and induction of intestinal IgA responses. J Immunol. 2009, 182 (5): 2610-2619. 10.4049/jimmunol.0801141.PubMed
26.
Schmucker DL, Thoreux K, Owen RL: Aging impairs intestinal immunity. Mech Ageing Dev. 2001, 122 (13): 1397-1411. 10.1016/S0047-6374(01)00276-7.PubMed
27.
Finkelstein MS, Tanner M, Freedman ML: Salivary and serum IgA levels in a geriatric outpatient population. J Clin Immunol. 1984, 4 (2): 85-91. 10.1007/BF00915040.PubMed
28.
Arranz E, O'Mahony S, Barton JR, Ferguson A: Immunosenescence and mucosal immunity: significant effects of old age on secretory IgA concentrations and intraepithelial lymphocyte counts. Gut. 1992, 33 (7): 882-886. 10.1136/gut.33.7.882.PubMedCentralPubMed
29.
Koga T, McGhee JR, Kato H, Kato R, Kiyono H, Fujihashi K: Evidence for early aging in the mucosal immune system. J Immunol. 2000, 165 (9): 5352-5359.PubMed
30.
Penn ND, Purkins L, Kelleher J, Heatley RV, Mascie-Taylor BH: Ageing and duodenal mucosal immunity. Age Ageing. 1991, 20 (1): 33-36. 10.1093/ageing/20.1.33.PubMed
31.
Senda S, Cheng E, Kawanishi H: Aging-associated changes in murine intestinal immunoglobulin A and M secretions. Scand J Immunol. 1988, 27 (2): 157-164. 10.1111/j.1365-3083.1988.tb02334.x.PubMed
32.
Thoreux K, Owen RL, Schmucker DL: Intestinal lymphocyte number, migration and antibody secretion in young and old rats. Immunology. 2000, 101 (1): 161-167. 10.1046/j.1365-2567.2000.00095.x.PubMedCentralPubMed
33.
Schmucker DL: Intestinal mucosal immunosenescence in rats. Exp Gerontol. 2002, 37 (2-3): 197-203. 10.1016/S0531-5565(01)00184-X.PubMed
34.
Fagarasan S, Muramatsu M, Suzuki K, Nagaoka H, Hiai H, Honjo T: Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science. 2002, 298 (5597): 1424-1427. 10.1126/science.1077336.PubMed
35.
McDonald LC, Owings M, Jernigan DB: Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis. 2006, 12 (3): 409-415.PubMedCentralPubMed
36.
Warny M, Vaerman JP, Avesani V, Delmee M: Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection. Infect Immun. 1994, 62 (2): 384-389.PubMedCentralPubMed
37.
Schmucker DL, Daniels CK, Wang RK, Smith K: Mucosal immune response to cholera toxin in ageing rats. I. Antibody and antibody-containing cell response. Immunology. 1988, 64 (4): 691-695.PubMedCentralPubMed
38.
Taylor LD, Daniels CK, Schmucker DL: Ageing compromises gastrointestinal mucosal immune response in the rhesus monkey. Immunology. 1992, 75 (4): 614-618.PubMedCentralPubMed
39.
Enioutina EY, Visic VD, Daynes RA: Enhancement of common mucosal immunity in aged mice following their supplementation with various antioxidants. Vaccine. 2000, 18 (22): 2381-2393. 10.1016/S0264-410X(00)00008-6.PubMed
40.
Chaplin DD, Fu Y: Cytokine regulation of secondary lymphoid organ development. Curr Opin Immunol. 1998, 10 (3): 289-297. 10.1016/S0952-7915(98)80167-2.PubMed
41.
De Togni P, Goellner J, Ruddle NH, Streeter PR, Fick A, Mariathasan S, Smith SC, Carlson R, Shornick LP, Strauss-Schoenberger J: Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science. 1994, 264 (5159): 703-707. 10.1126/science.8171322.PubMed
42.
Rennert PD, Browning JL, Hochman PS: Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization. Int Immunol. 1997, 9 (11): 1627-1639. 10.1093/intimm/9.11.1627.PubMed
43.
Rennert PD, Browning JL, Mebius R, Mackay F, Hochman PS: Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs. J Exp Med. 1996, 184 (5): 1999-2006. 10.1084/jem.184.5.1999.PubMed
44.
Fujimura Y, Kamoi R, Iida M: Pathogenesis of aphthoid ulcers in Crohn's disease: correlative findings by magnifying colonoscopy, electron microscopy, and immunohistochemistry. Gut. 1996, 38 (5): 724-732. 10.1136/gut.38.5.724.PubMedCentralPubMed
45.
Lockhart-Mummery HE, Morson BC: Crohn's disease (regional enteritis) of the large intestine and its distinction from ulcerative colitis. Gut. 1960, 1: 87-105. 10.1136/gut.1.2.87.PubMedCentralPubMed
46.
Tanaka Y, Imai T, Baba M, Ishikawa I, Uehira M, Nomiyama H, Yoshie O: Selective expression of liver and activation-regulated chemokine (LARC) in intestinal epithelium in mice and humans. Eur J Immunol. 1999, 29 (2): 633-642. 10.1002/(SICI)1521-4141(199902)29:02<633::AID-IMMU633>3.0.CO;2-I.PubMed
47.
Izadpanah A, Dwinell MB, Eckmann L, Varki NM, Kagnoff MF: Regulated MIP-3alpha/CCL20 production by human intestinal epithelium: mechanism for modulating mucosal immunity. Am J Physiol Gastrointest Liver Physiol. 2001, 280 (4): G710-719.PubMed
48.
Kaser A, Ludwiczek O, Holzmann S, Moschen AR, Weiss G, Enrich B, Graziadei I, Dunzendorfer S, Wiedermann CJ, Murzl E: Increased expression of CCL20 in human inflammatory bowel disease. J Clin Immunol. 2004, 24 (1): 74-85. 10.1023/B:JOCI.0000018066.46279.6b.PubMed
49.
Kwon JH, Keates S, Bassani L, Mayer LF, Keates AC: Colonic epithelial cells are a major site of macrophage inflammatory protein 3alpha (MIP-3alpha) production in normal colon and inflammatory bowel disease. Gut. 2002, 51 (6): 818-826. 10.1136/gut.51.6.818.PubMedCentralPubMed
50.
Bowman EP, Campbell JJ, Soler D, Dong Z, Manlongat N, Picarella D, Hardy RR, Butcher EC: Developmental switches in chemokine response profiles during B cell differentiation and maturation. J Exp Med. 2000, 191 (8): 1303-1318. 10.1084/jem.191.8.1303.PubMedCentralPubMed
51.
Ishimoto Y, Tomiyama-Miyaji C, Watanabe H, Yokoyama H, Ebe K, Tsubata S, Aoyagi Y, Abo T: Age-dependent variation in the proportion and number of intestinal lymphocyte subsets, especially natural killer T cells, double-positive CD4+ CD8+ cells and B220+ T cells, in mice. Immunology. 2004, 113 (3): 371-377. 10.1111/j.1365-2567.2004.01961.x.PubMedCentralPubMed
52.
Yamada K, Kimura Y, Nishimura H, Namii Y, Murase M, Yoshikai Y: Characterization of CD4+ CD8alphaalpha+ and CD4-CD8alphaalpha+ intestinal intraepithelial lymphocytes in rats. Int Immunol. 1999, 11 (1): 21-28. 10.1093/intimm/11.1.21.PubMed
53.
Jimenez E, Sacedon R, Vicente A, Hernandez-Lopez C, Zapata AG, Varas A: Rat peripheral CD4+CD8+ T lymphocytes are partially immunocompetent thymus-derived cells that undergo post-thymic maturation to become functionally mature CD4+ T lymphocytes. J Immunol. 2002, 168 (10): 5005-5013.PubMed
54.
Colombatti A, Doliana R, Schiappacassi M, Argentini C, Tonutti E, Feruglio C, Sala P: Age-related persistent clonal expansions of CD28(-) cells: phenotypic and molecular TCR analysis reveals both CD4(+) and CD4(+)CD8(+) cells with identical CDR3 sequences. Clin Immunol Immunopathol. 1998, 89 (1): 61-70. 10.1006/clin.1998.4580.PubMed
55.
Laux I, Khoshnan A, Tindell C, Bae D, Zhu X, June CH, Effros RB, Nel A: Response differences between human CD4(+) and CD8(+) T-cells during CD28 costimulation: implications for immune cell-based therapies and studies related to the expansion of double-positive T-cells during aging. Clin Immunol. 2000, 96 (3): 187-197. 10.1006/clim.2000.4902.PubMed
56.
Kenny E, Mason D, Saoudi A, Pombo A, Ramirez F: CD8 alpha is an activation marker for a subset of peripheral CD4 T cells. Eur J Immunol. 2004, 34 (5): 1262-1271. 10.1002/eji.200324363.PubMed
57.
Hori T, Paliard X, de Waal Malefijt R, Ranes M, Spits H: Comparative analysis of CD8 expressed on mature CD4+ CD8+ T cell clones cultured with IL-4 and that on CD8+ T cell clones: implication for functional significance of CD8 beta. Int Immunol. 1991, 3 (7): 737-741. 10.1093/intimm/3.7.737.PubMed
58.
Akari H, Terao K, Murayama Y, Nam KH, Yoshikawa Y: Peripheral blood CD4+CD8+ lymphocytes in cynomolgus monkeys are of resting memory T lineage. Int Immunol. 1997, 9 (4): 591-597. 10.1093/intimm/9.4.591.PubMed
59.
Parel Y, Chizzolini C: CD4+ CD8+ double positive (DP) T cells in health and disease. Autoimmun Rev. 2004, 3 (3): 215-220. 10.1016/j.autrev.2003.09.001.PubMed
60.
Lee WW, Nam KH, Terao K, Akari H, Yoshikawa Y: Age-related increase of peripheral CD4+ CD8+ double-positive T lymphocytes in cynomolgus monkeys: longitudinal study in relation to thymic involution. Immunology. 2003, 109 (2): 217-225. 10.1046/j.1365-2567.2003.01646.x.PubMedCentralPubMed
61.
Ebersole JL, Smith DJ, Taubman MA: Secretory immune responses in ageing rats. I. Immunoglobulin levels. Immunology. 1985, 56 (2): 345-350.PubMedCentralPubMed
62.
Gibson KL, Wu YC, Barnett Y, Duggan O, Vaughan R, Kondeatis E, Nilsson BO, Wikby A, Kipling D, Dunn-Walters DK: B-cell diversity decreases in old age and is correlated with poor health status. Aging Cell. 2009, 8 (1): 18-25. 10.1111/j.1474-9726.2008.00443.x.PubMedCentralPubMed
63.
Cancro MP, Hao Y, Scholz JL, Riley RL, Frasca D, Dunn-Walters DK, Blomberg BB: B cells and aging: molecules and mechanisms. Trends Immunol. 2009, 30 (7): 313-318. 10.1016/j.it.2009.04.005.PubMedCentralPubMed
64.
Tsuji M, Suzuki K, Kitamura H, Maruya M, Kinoshita K, Ivanov II, Itoh K, Littman DR, Fagarasan S: Requirement for lymphoid tissue-inducer cells in isolated follicle formation and T cell-independent immunoglobulin A generation in the gut. Immunity. 2008, 29 (2): 261-271. 10.1016/j.immuni.2008.05.014.PubMed
65.
Stoel M, Jiang HQ, van Diemen CC, Bun JC, Dammers PM, Thurnheer MC, Kroese FG, Cebra JJ, Bos NA: Restricted IgA repertoire in both B-1 and B-2 cell-derived gut plasmablasts. J Immunol. 2005, 174 (2): 1046-1054.PubMed
Metadata
Title
Aging impacts isolated lymphoid follicle development and function
Authors
Keely G McDonald
Matthew R Leach
Conway Huang
Caihong Wang
Rodney D Newberry
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Immunity & Ageing / Issue 1/2011
Electronic ISSN: 1742-4933
DOI
https://doi.org/10.1186/1742-4933-8-1

Other articles of this Issue 1/2011

Immunity & Ageing 1/2011 Go to the issue

Short report

Age-related decrease of miRNA-92a levels in human CD8+ T-cells correlates with a reduction of naïve T lymphocytes

Review

Immunopathogenesis of primary biliary cirrhosis: an old wives' tale

Research

Differential effects of age, cytomegalovirus-seropositivity and end-stage renal disease (ESRD) on circulating T lymphocyte subsets

Review

The "Alzheimer's disease signature": potential perspectives for novel biomarkers

Research

Decline of influenza-specific CD8+ T cell repertoire in healthy geriatric donors

Research

Identification of serum biomarkers for aging and anabolic response
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits